www.rupeedesk.in
The movement in stocks of major pharmaceutical companies is likely to be positive next week as investors are expected to bet more on defensive stocks such as pharma and fast moving consumer goods. Higher focus is likely on defensive stocks as investors would be cautious ahead of the economic data Consumer Price Index inflation for December to be released early next week. The Index of Industrial Production for November was released earlier yesterday. Stocks of major drug makers may not gain much if the pressure from a negative Nifty spills over to the sector. Dr Reddy's Laboratories Ltd and Divi's Laboratories Ltd are expected to outperform next week based on their recent charts. Cadila Healthcare Ltd's stocks are likely to continue upward run and may touch 950-960- rupee levels by the end of January. Stocks of Cadila Healthcare yesterday closed at 872.05 rupees on the National Stock Exchange, up 11.69% from Jan 3 close. The stock rallied after it received the US drug regulator's nod to sell drugs in the country. Giving a sideways-to-positive view on Lupin Ltd. It is important for it (Lupin's stocks) to close above 950 rupees for us to have a positive view on it.
The movement in stocks of major pharmaceutical companies is likely to be positive next week as investors are expected to bet more on defensive stocks such as pharma and fast moving consumer goods. Higher focus is likely on defensive stocks as investors would be cautious ahead of the economic data Consumer Price Index inflation for December to be released early next week. The Index of Industrial Production for November was released earlier yesterday. Stocks of major drug makers may not gain much if the pressure from a negative Nifty spills over to the sector. Dr Reddy's Laboratories Ltd and Divi's Laboratories Ltd are expected to outperform next week based on their recent charts. Cadila Healthcare Ltd's stocks are likely to continue upward run and may touch 950-960- rupee levels by the end of January. Stocks of Cadila Healthcare yesterday closed at 872.05 rupees on the National Stock Exchange, up 11.69% from Jan 3 close. The stock rallied after it received the US drug regulator's nod to sell drugs in the country. Giving a sideways-to-positive view on Lupin Ltd. It is important for it (Lupin's stocks) to close above 950 rupees for us to have a positive view on it.
